Sat, Jan 31, 2015, 8:56 AM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Immune Pharmaceuticals, Inc. Message Board

  • klr8ball klr8ball Sep 26, 2006 11:35 AM Flag

    After yesterdays news...

    I'm surprised we don't get more traffic. Obviously everyone is still going crazy over ACOR!!

    I'm hoping some of the profits make there way over here. If of course people get out soon and lock in those profits!!

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • News are more then one month old! Come on! Same thing happened in mars when the share soared. Does EpiCept have any information director? One could not thing so.
      Todays "news" couldn't have come at a more suitable time. Think they'll do anything trying to get positive attention the next couple of weeks just to avoid delisting, no matter if it's old news...

      "Salt Lake City, August 22, 2006
      In our Phase 1 study of Azixa� in cancer that has metastasized to the brain, the drug has recently achieved its maximum tolerated dose in patients. Interestingly, we noted a measurable reduction in tumor size in certain patients, suggesting evidence of activity. Myriad is now finalizing the therapeutic dose and regimen to take Azixa forward into Phase 2 trials beginning this fall."
      http://www.myriad.com/news/release/898035

      Haven't seen any data that states that the results are statistically established. I know for sure that "certain patients" won't be enought to justify a FAS II study.

 
IMNP
1.78-0.020(-1.11%)Jan 30 3:58 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.